News and ViewsRecent Price Movement and Market Context
On 02-Feb, Glenmark Pharmaceuticals closed at ₹1,937.40, down by ₹1.95 or 0.1%. This slight fall comes after two consecutive days of losses, during which the stock declined by nearly 3.94%. The intraday low touched ₹1,842.80, marking a 4.98% drop from recent highs. Notably, the weighted average price indicates that a larger volume of shares traded closer to the day’s low, suggesting some selling pressure during the session.
The stock’s performance over the past week and month has been weaker relative to the benchmark Sensex. While the Sensex gained 0.16% in the last week, Glenmark’s shares fell by 1.69%. Over the past month, the stock declined 6.45%, underperforming the Sensex’s 4.78% drop. Year-to-date, the stock is down 4.84%,...
Read full news article
